Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease

被引：0
|
作者：
Clifford J. Bailey
Caroline Day
Srikanth Bellary
机构：
[1] Aston University,Life and Health Sciences
来源：
Current Diabetes Reports | 2022年 / 22卷
关键词：
Sodium-glucose co-transporter-2 (SGLT2) inhibitors; Diabetic kidney disease; Chronic kidney disease; Albuminuria; Acute kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：39 / 52
页数：13
相关论文
共 50 条
  • [21] Renal and cardiac effects of SGLT2 inhibitors
    Menne J.
    Der Nephrologe, 2017, 12 (2): : 90 - 96
  • [22] Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal Anemia
    Packer, Milton
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (02) : 255 - 259
  • [23] Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease
    Scheen, Andre J.
    Delanaye, Pierre
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (01) : 35 - 46
  • [24] Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients
    Chen, Xiutian
    Wang, Jiali
    Lin, Yongda
    Yao, Kaijin
    Xie, Yina
    Zhou, Tianbiao
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [25] SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice
    Skrabic, Roko
    Kumric, Marko
    Vrdoljak, Josip
    Rusic, Doris
    Skrabic, Ivna
    Vilovic, Marino
    Martinovic, Dinko
    Duplancic, Vid
    Kurir, Tina Ticinovic
    Bozic, Josko
    BIOMEDICINES, 2022, 10 (10)
  • [26] SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
    Podesta, Manuel Alfredo
    Sabiu, Gianmarco
    Galassi, Andrea
    Ciceri, Paola
    Cozzolino, Mario
    BIOMEDICINES, 2023, 11 (02)
  • [27] Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
    Mende, Christian W.
    ADVANCES IN THERAPY, 2022, 39 (01) : 148 - 164
  • [28] Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
    Christian W. Mende
    Advances in Therapy, 2022, 39 : 148 - 164
  • [29] SGLT2 inhibitors to prevent diabetic kidney disease
    Fioretto, Paola
    Vettor, Roberto
    Pontremoli, Roberto
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (01): : 4 - 5
  • [30] Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease
    Nakagawa, Takahiko
    Sanchez-Lozada, Laura G.
    Andres-Hernando, Ana
    Kojima, Hideto
    Kasahara, Masato
    Rodriguez-Iturbe, Bernardo
    Bjornstad, Petter
    Lanaspa, Miguel A.
    Johnson, Richard J.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345